PPP2R3C and cancer: To date, there have been no reports of altered G5PR (PPP2R3C) expression in cancer; however, its role in the maturation of B-cells has been well investigated and may represent an attractive candidate for holoenzyme stabilization to drive an robust immune infiltration response in vulnerable cancer subtypes (138, 139, 140, 141).